Ocugen, Inc/$OCGN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Ocugen, Inc
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
- Ticker
- $OCGN
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 116
- Headquarters
- Malvern, United States
- Website
- www.ocugen.com
Ocugen, Inc Metrics
BasicAdvanced
$277M
-
-$0.20
1.98
-
Price and volume
Market cap
$277M
Beta
1.98
52-week high
$2.73
52-week low
$0.69
Average daily volume
6.8M
Financial strength
Current ratio
0.769
Quick ratio
0.709
Long term debt to equity
-0.258
Total debt to equity
-5.009
Interest coverage (TTM)
-6.76%
Profitability
EBITDA (TTM)
-67.669
Gross margin (TTM)
-843.81%
Net profit margin (TTM)
-1,367.34%
Operating margin (TTM)
-1,444.14%
Revenue per employee (TTM)
$40,000
Management effectiveness
Return on assets (TTM)
-52.09%
Return on equity (TTM)
923.93%
Valuation
Price to revenue (TTM)
56.287
Price to book
-15.67
Price to tangible book (TTM)
-15.67
Growth
Revenue change (TTM)
-10.99%
Earnings per share change (TTM)
-8.66%
3-year revenue growth (CAGR)
-12.42%
3-year earnings per share growth (CAGR)
-16.28%
What the Analysts think about Ocugen, Inc
Analyst ratings (Buy, Hold, Sell) for Ocugen, Inc stock.
Analyst projections of the future price of Ocugen, Inc stock.
Ocugen, Inc Financial Performance
Revenues and expenses
Ocugen, Inc Earnings Performance
Company profitability
Upcoming events
No upcoming events
Ocugen, Inc News
AllArticlesVideos
Funds containing Ocugen, Inc
Fund name | Fund size | $OCGN weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.02% |
iShares Ageing Population£AGES | $953M | 0.02% |
iShares Ageing Population€AGED | $903M | 0.02% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.01% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.